TCT · San Diego · 2026-10-31 – 2026-11-03

TCT 2026

0 de 28 ensayos Late-Breaking con resultado

Los resultados están embargados hasta cada presentación y aparecen aquí cuando se publican.

sáb, 31 oct

10:45–12:13 (America/Los_Angeles) · Main Arena · Hall H

10:45P4Estudio clínico · Carlos ColletCoronary CT Angiography-Guided vs. IVUS-Guided PCI: The Randomized P4 TrialPresentado — resultado pendiente
11:07TRANSFORM IIEstudio clínico · Bernardo CorteseSirolimus Coated Balloons vs. Drug-eluting Stents in Native Coronary Vessels: The TRANSFORM II Randomized TrialPresentado — resultado pendiente
11:29HD-PCIEstudio clínico · Sanjit S. JollyA Randomized Trial of Higher vs. Lower Dose Heparin for PCI: The HD-PCI TrialPresentado — resultado pendiente
11:51REMEDY-PILOTEstudio clínico · Kevin ChengCoronary Sinus Reducer for Refractory Angina in ANOCA: A Randomized Double-Blind Sham-Controlled Trial (REMEDY-PILOT)Presentado — resultado pendiente

14:15–15:45 (America/Los_Angeles) · Main Arena · Hall H

14:15VERITASEstudio clínico · Dhanunjaya LakkireddyOne-Year Outcomes with the Amulet 360 Device for Left Atrial Appendage Closure: The VERITAS Amulet 360 StudyPresentado — resultado pendiente
14:33Community TR cohortEstudio observacional · Rebecca T. HahnCharacteristics and Clinical Outcomes of Tricuspid Regurgitation in the Community: Insights from a Real-World Cohort of 180,977 Men and WomenPresentado — resultado pendiente
14:51TRAVEL IIIEstudio clínico · Junbo GeTranscatheter Tricuspid Valve Replacement with the LuX-Valve Plus System vs. Medical Therapy for Severe TR: The Randomized TRAVEL III TrialPresentado — resultado pendiente
15:09TRIC-I-HF subgroupsEstudio observacional · Jörg HausleiterTranscatheter Tricuspid Valve Intervention in Heart Failure: Key Subgroup Results from the TRIC-I-HF-DZHK24 TrialPresentado — resultado pendiente
15:27EARLY TAVR economicsEstudio observacional · Neel ButalaEconomic Outcomes and Cost-Effectiveness of TAVR for Asymptomatic Severe Aortic Stenosis: Results from the EARLY TAVR TrialPresentado — resultado pendiente

09:40–11:10 (America/Los_Angeles) · Main Arena · Hall H

09:40PROGRESSEstudio clínico · Philippe GenereuxTAVR or Clinical Surveillance for Moderate Aortic Stenosis: Primary Results of the PROGRESS Randomized TrialPresentado — resultado pendiente
10:04GBD degenerative mitral valve diseaseEstudio observacional · Juan F. GranadaGlobal Burden and Outcomes of Degenerative Mitral Valve Disease: A 30-Year Analysis of the Global Burden of Disease StudyPresentado — resultado pendiente
10:25CLASP II TREstudio clínico · Suzanne V. Arnold, Charles J. DavidsonTranscatheter Tricuspid Valve Repair with the PASCAL System vs. Medical Therapy for Severe, Symptomatic Tricuspid Regurgitation: Clinical and Health Status Outcomes from the CLASP II TR Randomized TrialPresentado — resultado pendiente
10:49SIMPLAAFYEstudio clínico · Saibal KarAntithrombotic Monotherapy After Left Atrial Appendage Occlusion: Primary Results of the SIMPLAAFY Randomized TrialPresentado — resultado pendiente

14:15–15:45 (America/Los_Angeles) · Main Arena · Hall H

14:15PeriSorbEstudio clínico · Yuan CheOne-Year Outcomes of the PeriSorb Bioresorbable Vascular Scaffold vs. Drug-Coated Balloon for Superficial Femoral Artery Disease: A Multicenter Randomized TrialPresentado — resultado pendiente
14:33SIRONAEstudio clínico · Ulf TeichgräberThree-Year Outcomes of Sirolimus vs. Paclitaxel-Coated Balloons for Femoropopliteal Artery Disease: The Randomized SIRONA TrialPresentado — resultado pendiente
14:51AIR STEMI non-culprit severityEstudio observacional · Simone BiscagliaImpact of Non-Culprit Lesion Severity on the Utility of Functional Coronary Angiography in Patients with STEMI and Multivessel Disease: The AIR STEMI Randomized TrialPresentado — resultado pendiente
15:09LIPSIA-STRATEGYEstudio clínico · Nicolas MajunkeAngiography-Derived FFR Versus vs. Wire-Based FFR to Guide Coronary Revascularization: The LIPSIA-STRATEGY TrialPresentación lun, 15:09
15:27Nicorandil no-reflow trialEstudio clínico · Takashi MuramatsuIntracoronary Delivery of Nicorandil for Prevention of No-Reflow in Patients Undergoing Primary PCI for STEMI: A Multicenter Randomized TrialPresentación lun, 15:27

10:45–12:15 (America/Los_Angeles) · Main Arena · Hall H

10:45PIONEER IVEstudio clínico · Patrick W. SerruysAngiography-Derived FFR vs. Usual Care for Lesion Selection and Optimization in All-Comers PCI: Final Results of the PIONEER IV Randomized TrialPresentación mar, 10:45
11:03EPIC17-VERONICAEstudio clínico · Iñigo LozanoPlatelet Function Testing to Guide P2Y12 Inhibitor De-Escalation After ACS: The EPIC17-VERONICA Randomized TrialPresentación mar, 11:03
11:21SPYRAL AFFIRMEstudio clínico · David E. KandzariSafety and Effectiveness of Radiofrequency Renal Denervation in the United States: Primary Results of the SPYRAL AFFIRM Post-Approval StudyPresentación mar, 11:21
11:39SINGLE-CLOSUREEstudio clínico · Jun JiangSingle vs. Double ProGlide Devices for Access Site Closure After Transfemoral TAVR: The SINGLE-CLOSURE TrialPresentación mar, 11:39
11:57IRIS-MAINEstudio observacional · Duk-Woo ParkLong-Term Survival after Coronary Revascularization for Unprotected Left Main Disease (the IRIS-MAIN Registry): A Prospective, Multicenter, Multinational Cohort StudyPresentación mar, 11:57

12:20–13:50 (America/Los_Angeles) · Main Arena · Hall H

12:20ENCIRCLEEstudio clínico · John G. WebbPercutaneous Transcatheter Mitral Valve Replacement in Patients with Symptomatic Mitral Regurgitation: 2-Year Outcomes from the ENCIRCLE TrialPresentación mar, 12:20
12:38PROTEMBOEstudio clínico · Susheel K. KodaliThe ProtEmbo® Cerebral Protection System During TAVR: Final Results of the Randomized PROTEMBO IDE TrialPresentación mar, 12:38
12:56JENA-VADEstudio clínico · Torsten P. VahlTranscatheter Aortic Valve Replacement with the JenaValve Trilogy System for Aortic Regurgitation in Patients with a Left Ventricular Assist Device: The JENA-VAD StudyPresentación mar, 12:56
13:14DUOTAPEstudio clínico · Maximilian AutherithRoutine Post-Dilation vs. Conventional Deployment for Balloon-Expandable TAVR: The Randomized DUOTAP TrialPresentación mar, 13:14
13:32TAVR vs SAVR for aortic regurgitationEstudio clínico · YAOFU ZHENGTranscatheter vs. Surgical AVR for Symptomatic, Severe Aortic Regurgitation: One-Year Outcomes from a Multicenter Randomized TrialPresentación mar, 13:32